Company profile: Cansford Laboratories
1.1 - Company Overview
Company description
- Provider of laboratory drug, alcohol, and DNA testing with professional collection services, including hair drug testing (up to 6-month window), PEth blood testing via finger prick (detects alcohol use within 1-2 hours and up to 28 days), legally defensible DNA testing for family law, hair alcohol testing (EtG/FAEE), oral fluid testing (recent drug use up to 48 hours), and hair steroid testing (anabolic steroids, DHEA, testosterone).
Products and services
- DNA Testing: Legally defensible DNA testing for family law that verifies relationships using oral swabs for sample collection
- Hair Drug Testing: Laboratory-based hair strand analysis identifies drug use with a detection window of up to 6 months
- PEth Testing: Blood test using finger prick collection detects alcohol use as soon as 1–2 hours and up to 28 days, delivers both immediate and extended detection windows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cansford Laboratories
Diagnost-iQ
HQ: The Netherlands
Website
- Description: Provider of clinical chemistry and diagnostic services, including blood, urine, and other fluid analyses to detect diseases and monitor treatment, as well as antibody reagents for flow cytometry. Offers blood collection at various locations, with appointments or walk-ins, home collection in some regions, and a thrombosis service for monitoring patients on anticoagulant therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnost-iQ company profile →
Medneo
HQ: United Kingdom
Website
- Description: Provider of diagnostic imaging services, including medical imaging, scanning, contrast imaging, and ultrasound imaging to enhance patient care and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medneo company profile →
Center for Human Genetics and Laboratory Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic expertise in analysis of body fluids and tissue samples using molecular genetic, cytogenetic, flow cytometric, and biochemical techniques, with a molecular diagnostics portfolio spanning advanced technologies such as multi-gene panel sequencing (MGPS), clinical exome sequencing (CES), and whole exome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Center for Human Genetics and Laboratory Diagnostics company profile →
Ambry Genetics
HQ: United States
Website
- Description: Provider of clinical genetic diagnostics and genetics software solutions, offering a comprehensive suite of genetic testing including clinical diagnostic exome sequencing, a proprietary ACMG-based variant classification scheme, family studies for co-segregation analysis, and +RNAinsight testing of up to 91 genes; benefiting 90% of U.S. patients covered by public and private insurers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambry Genetics company profile →
Edda Technology
HQ: United States
Website
- Description: Provider of computer-assisted 3D medical imaging software and guidance tools, including IQQA-BodyImaging for analysis and visualization of liver, lung, and kidney to support surgical planning and assessment; IQQA-Guide for real-time 3D guidance in abdominal and thoracic procedures; and IQQA-BodyImaging Interventional for precision analytics aiding needle placement for ablation and biopsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Edda Technology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cansford Laboratories
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cansford Laboratories
2.2 - Growth funds investing in similar companies to Cansford Laboratories
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cansford Laboratories
4.2 - Public trading comparable groups for Cansford Laboratories
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →